{
  "ticker": "BIO",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969291",
  "id": "02969291",
  "pages": 6,
  "price_sensitive": true,
  "date": "20250715",
  "time": "0842",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250715/pdf/06lsyhcncjwzr2.pdf",
  "summary": "- **International Sales Revenue**: FY25 international sales of $1.5M, up 69% YoY (FY24: $0.89M).  \n- **New Distribution Agreements**: Secured in Q4 FY25:  \n  - **Ireland**: Uniphar (1,400+ pharmacy customers).  \n  - **New Zealand**: Propharma (EBOS Group, largest pharmacy wholesaler).  \n  - **Canada**: Deals with Pure Pharmacy, Healthy Planet, Nature\u2019s Emporium, and Nature\u2019s Signature.  \n- **Market Expansion**: New distribution channels to drive growth in FY26, with rollout starting Q1 FY26.  \n- **Canadian Demand**: Exceeded expectations; practitioner market orders and local sales team established.  \n- **Product Pipeline**: New products planned for Canada pending Health Canada registration in FY26.",
  "usage": {
    "prompt_tokens": 2303,
    "completion_tokens": 177,
    "total_tokens": 2480,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-14T22:55:03.903503"
}